Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sickle cell disease.

Jason Fixler1, Lori Styles

  • 1Children's Hospital and Research Center at Oakland, Department of Hematology/Oncology, 747 52nd Street, Oakland, CA 94609, USA.

Pediatric Clinics of North America
|February 13, 2003
PubMed
Summary

Sickle cell disease is a serious genetic blood disorder affecting African-Americans. This review covers current knowledge on sickle cell disease complications and potential treatments for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain Metastasis in Pediatric Patients with Osteosarcoma.

Current oncology (Toronto, Ont.)·2024
Same author

A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024
Same author

Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study.

Transplantation and cellular therapy·2022
Same author

Ibrutinib for Hospitalized Adults With Severe Coronavirus Disease 2019 Infection: Results of the Randomized, Double-Blind, Placebo-Controlled iNSPIRE Study.

Open forum infectious diseases·2022
Same author

Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study.

Annals of hematology·2021

Area of Science:

  • Hematology
  • Genetics
  • Pediatrics

Background:

  • Sickle cell disease (SCD) is a severe, inherited blood disorder impacting approximately 1 in 600 African Americans.
  • First described in 1910, medical understanding and therapeutic strategies for SCD have significantly advanced.
  • Pediatricians frequently encounter children with SCD, necessitating comprehensive knowledge of the condition.

Purpose of the Study:

  • To provide an updated summary of current knowledge regarding sickle cell disease.
  • To detail the known complications associated with sickle cell disease.
  • To outline potential treatment options for individuals with sickle cell disease.

Main Methods:

  • This article is a review of existing literature on sickle cell disease.
  • It synthesizes current understanding of the disease's pathophysiology and clinical manifestations.
  • Information on complications and treatments is compiled from established medical resources.

Main Results:

  • Sickle cell disease presents with a range of serious complications affecting multiple organ systems.
  • Various treatment modalities exist, aimed at managing symptoms and preventing complications.
  • Ongoing research continues to explore novel therapeutic approaches for SCD.

Conclusions:

  • A thorough understanding of sickle cell disease, its complications, and treatments is crucial for healthcare providers, especially pediatricians.
  • Effective management requires a comprehensive approach addressing the multifaceted nature of the disease.
  • Continued research and clinical advancements offer hope for improved outcomes in sickle cell disease patients.

Related Experiment Videos